Biodexa Pharmaceuticals Plc (BDRX) Stock Forecast
BDRX analyst forecast
as of October 17, 2026- Analyst consensus
- —
- Price target
- $8.97 average of analyst targets
- Upside to target
- +1,867.5% from the latest close
- Next earnings
- —
- 52-week range
- $0.35 – $44.00
BDRX price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
BDRX earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.00 | $0.00 | $0.00 | — | — | 1 |
| Current fiscal year (2026) | $0.00 | $0.00 | $0.00 | −$0.00 | +100.0% | 1 |
| Next fiscal year (2027) | $0.00 | $0.00 | $0.00 | $0.00 | 0.0% | 1 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
BDRX revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0 | $0 | $0 | — | 1 |
| Current fiscal year (2026) | $0 | $0 | $0 | 0.0% | 1 |
| Next fiscal year (2027) | $0 | $0 | $0 | 0.0% | 1 |
BDRX EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
BDRX EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | 0 up · 0 down |
| Current fiscal year (2026) | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | 1 up · 0 down |
| Next fiscal year (2027) | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | 1 up · 0 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
BDRX earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; BDRX beat in 10 of 12.
What analysts expect from BDRX
The average price target is $8.97, 1,867.5% above the latest close of $0.46. Analysts expect earnings of $0.00 per share for 2026, +100.0% from a year earlier. For 2027 the average estimate is $0.00 per share. Biodexa Pharmaceuticals Plc beat the EPS estimate in 10 of the last 12 quarters.
Related: BDRX income statement, BDRX key metrics, BDRX chart. See the BDRX stock overview for the latest quote and news.
BDRX forecast FAQ
What is Biodexa Pharmaceuticals Plc's price target?
The average analyst price target for Biodexa Pharmaceuticals Plc is $8.97, 1,867.5% above the latest close of $0.46.
What is Biodexa Pharmaceuticals Plc's EPS forecast?
Analysts forecast $0.00 per share for 2026 (range $0.00 to $0.00); for 2027 the estimate is $0.00.
Does Biodexa Pharmaceuticals Plc usually beat earnings estimates?
Biodexa Pharmaceuticals Plc reported EPS at or above the analyst estimate in 10 of the last 12 quarters.